Camille Sebaaly
Net Worth
Last updated:
What is Camille Sebaaly net worth?
The estimated net worth of Mr. Camille Sebaaly is at least $309,485 as of 30 Nov 2022. He owns shares worth $249,485 as insider and has received compensation worth at least $60,000 in Sunshine Biopharma, Inc..
What is the salary of Camille Sebaaly?
Mr. Camille Sebaaly salary is $20,000 per year as Chief Financial Officer & Sec. in Sunshine Biopharma, Inc..
How old is Camille Sebaaly?
Mr. Camille Sebaaly is 66 years old, born in 1959.
What stocks does Camille Sebaaly currently own?
As insider, Mr. Camille Sebaaly owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Sunshine Biopharma, Inc. (SBFM) | Chief Financial Officer & Sec. | 174,465 | $1.43 | $249,485 |
What does Sunshine Biopharma, Inc. do?
Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.
Camille Sebaaly insider trading
Sunshine Biopharma key executives
Sunshine Biopharma, Inc. executives and other stock owners filed with the SEC:
- Dr. Abderrazzak Merzouki (61) Chief Operating Officer & Director
- Dr. Steve N. Slilaty Ph.D. (73) Chairman, Chief Executive Officer & Pres
- Mr. Camille Sebaaly (66) Chief Financial Officer & Sec.